Tension-type Headache
📧 Sign up to get email alerts when something new happens for Tension-type Headache.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Mulligan Mobilizations Versus Active Release Technique in Tension-type Headache. [NA]
A clinical trial compares Mulligan Mobilizations with Active Release Technique for tension-type headache, and the study status is NOT_YET_RE…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache Patients
A completed clinical trial update describing an internet-based survey and NLP analysis project that collects and analyzes written monologues…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Effectiveness of the Dry Needling Approach in Patients With Tension-Type Headache [NA]
A completed clinical trial assessing the effectiveness of dry needling for treating tension-type headaches.
-
FDA approval · 2024-02-08FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved an original application for a generic fixed-dose combination of butalbital, acetaminophen and caffeine from Quagen Pharmaceutic…
-
FDA approval · 2024-02-01FDA Approved: BUTALBITAL AND ACETAMINOPHEN — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approves an original ANDA for Butalbital and Acetaminophen from Quagen Pharmaceuticals LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-08-16FDA Approved: BUTALBITAL AND ACETAMINOPHEN — Original Application (Aarkish Pharmaceuticals NJ Inc.)
FDA approved an original application for a generic butalbital and acetaminophen product from Aarkish Pharmaceuticals NJ Inc., authorizing it…
-
FDA approval · 2022-04-07FDA Approved: BUTALBITAL AND ACETAMINOPHEN — Original Application (Amici Pharma, Inc.)
The FDA approved Amici Pharma, Inc.'s original application for a generic Butalbital and Acetaminophen product.
-
FDA approval · 2022-01-26FDA Approved: BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA's generic fixed-dose combination of butalbital, acetaminophen, caffeine and codeine phosphate (Origin…
-
FDA approval · 2021-10-18FDA Approved: BUTALBITAL, ASPIRIN, AND CAFFEINE — Original Application (LGM PHARMA SOLUTIONS, LLC)
FDA approved the original application for butalbital, aspirin, and caffeine (Butalbital, Aspirin, and Caffeine) submitted by LGM Pharma Solu…
-
FDA approval · 2021-09-29FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (AiPing Pharmaceutical, Inc.)
FDA approved a supplemental application for Amitriptyline Hydrochloride, a generic product submitted by AiPing Pharmaceutical, Inc., under t…
-
FDA approval · 2021-08-13FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Original Application (Amici Pharma, Inc.)
The FDA approved Amici Pharma's generic Butalbital, Acetaminophen and Caffeine under an original ANDA, providing a generic option for analge…
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: A Study to Describe Pain Intensity, Pain Relief and Safety of Neosaldina in the Treatment of Tension-type Headaches (TTH) in Healthy Participants
Clinical trial update describing pain intensity, pain relief, and safety of Neosaldina in tension-type headaches and healthy participants; s…
-
FDA approval · 2021-03-04FDA Approved: BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for the analgesic combination butalbital/acetaminophen/caffeine/codeine phosphate from Actavis Pharm…
-
CLINICAL_TRIALS withdrawal · 2021-02-24Clinical Trial Update: Non-Inferiority Comparison of Migrane® Versus Parcel ® For Treatment of Tensional Cephaleia [Phase 3]
A Phase 3 trial comparing Migrane® to Parcel® for tension-type headache was withdrawn.
-
FDA approval · 2020-04-08FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved the original application for a generic fixed-dose combination of butalbital, acetaminophen, and caffeine (Granules Pharmaceutic…
-
FDA approval · 2019-12-17FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Original Application (Lannett Company, Inc.)
FDA approved an original ANDA for a generic Butalbital/acetaminophen/caffeine combination (butalbital, acetaminophen and caffeine) by Lannet…
-
FDA approval · 2019-11-22FDA Approved: BUTALBITAL AND ACETAMINOPHEN — Original Application (Granules Pharmaceuticals Inc.)
FDA approves Granules Pharmaceuticals Inc.'s original ANDA for a generic Butalbital and Acetaminophen product.
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Exercise in Migraine and Co-existing Tension-type Headache and Neck Pain [NA]
This clinical trial, sponsored by the Danish Headache Center, evaluated exercise as an intervention for people with migraine and co-existing…
-
FDA approval · 2018-10-31FDA Approved: BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE — Original Application (LGM PHARMA SOLUTIONS, LLC)
FDA approved a generic version of the combination analgesic butalbital, acetaminophen, and caffeine for headache indications.
-
FDA approval · 2018-09-18FDA Approved: FIORICET WITH CODEINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Fioricet with Codeine (butalbital/acetaminophen/caffeine/codeine phosphate) from Actavis Pha…
-
FDA approval · 2018-09-18FDA Approved: BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for the analgesic combination Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate from Actavi…
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Ketamine v. Ketorolac for Management of Generalized Tension Type Headache [Phase 4]
Phase 4 clinical trial comparing ketamine to ketorolac for managing generalized tension-type headache; current status is unknown.
-
CLINICAL_TRIALS withdrawal · 2018-06-04Clinical Trial Update: Evidence-Based Osteopathy for Tension-Type Headache (EBOTTH) [NA]
A clinical trial evaluating evidence-based osteopathy for tension-type headache has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Diacutaneous Fibrolysis, Effects on Tension Type Headache [NA]
A completed clinical trial assessed the effects of diacutaneous fibrolysis on tension-type headache.
-
CLINICAL_TRIALS trial_result · 2018-04-30Clinical Trial Update: Sub-occipital Muscle Inhibition in Tension Type Headache [NA]
A clinical trial evaluating sub-occipital muscle inhibition for tension-type headache has completed.